Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Conditions
Interventions
Intervention1: Face-to-face genetic counselling: All cases diagnosed with ovarian cancer will undergo genetic counselling of 40-60minutes.
Control Intervention1: Telegentics: Another group diagnosed w
Sponsors
DR SUVIDYA SINGH
Eligibility
Inclusion criteria
Inclusion criteria: All women with epithelial ovarian cancer, Recurrent ovarian cancer, Willing to participate
Exclusion criteria
Exclusion criteria: Non epithelial ovarian cancer,Patients not having access to internet and WhatsApp application in smart phone, Previous genetic counselling or genetic testing, All women with inadequate proficiency with Hindi/English language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare acceptance for undergoing genetic testing in women with EOC, undergoing tele-genetics versus in-person genetic counselling by clinical team. To compare the satisfaction of women with EOC undergoing tele-genetics versus in-person genetic counselling by clinical team, using the mean genetic counselling satisfaction score (GCSS). Timepoint: Will be recorded 1 week after genetic counselling session | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the Knowledge & attitude of women with EOC regarding genetic testing 2. To compare the attendance of genetic counselling in telegenetics vs in-person genetic counselling 3. To assess the impact of factors leading to delay in seeking medical care in these patients on acceptance of genetic testing 4. To assess the barriers towards genetic testing in women with EOC 5. Comparison of time taken in each group & number of visits/sessions in each arm Timepoint: After 1 week of genetic counselling | — |
Countries
India
Contacts
Public ContactDr Seema Singhal
AIIMS, NEW DELHI
Outcome results
None listed